ARS Pharmaceuticals Inc — Cash Flow (NASDAQ:SPRY) | MetaTrader

Open full chart

Financials

Overview 明細書 Statistics Dividends

Quarterly Annual

Cash from operating activities 66.76 M40.08 M59.27 M13.55 M 112.47 M Cash from investing activities 66.48 M199 K87.18 M106.1 M 134.41 M Cash from financing activities 614 K190.73 M6.9 M72.4 M 174.38 M Free cash flow 65.39 M39.88 M59.09 M12.98 M 111.83 M

ニュース

ARS Pharmaceuticals Stock: Climbing Neffy Sales Global Expansion Re-Rate (NASDAQ:SPRY)

リードアレルギー治療薬のFDA更新後、アクエスティブ・セラピューティクス株の動向はどうなっていますか？

What's Going On With ARS Pharmaceuticals Stock Friday? - ARS Pharmaceuticals (NASDAQ:SPRY)

Why Is Aquestive Therapeutics Stock Falling Today? - Aquestive Therapeutics (NASDAQ:AQST)

中国、アレルギー用エピネフリン鼻腔スプレーの初の一般使用を承認

China approves first community use epinephrine nasal spray for allergies

ARS ファーマ、チャクマCBOが1.47百万ドル相当の株式を売却

ドーシー氏、ARS ファーマのCOO、SPRYの株式を19万ドル分売却

ARS Pharma CBO Chakma sells shares worth $1.47 million

Dorsey, ARS Pharma COO, sells $190k in SPRY stock

ARS Pharmaceuticals, Inc. (SPRY) Q3 2025 Earnings Call Transcript

ARS ファーマシューティカルズ、好調な第3四半期売上でレイモンド・ジェームズが「強い買い」を再確認